Clinical Trials in New York

Showing 12421-12440 of 22,668 trials

Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients

NCT02987829

This is a multi-center, first-in-human, open-label, Phase 1/2A dose-escalation study in which eligible patients with metastatic castration-resistant prostate carcinoma (mCRPC) will receive oral doses of TRC253. The study will be conducted in 2 parts: part 1 (dose escalation) and part 2 (dose expansion).

Metastatic Castrate-resistant Prostate CancerAdenocarcinoma, Prostate

Tracon Pharmaceuticals Inc.72 participantsStarted May 2017

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • Santa Monica, California, United States +2 more locations

COMPLETEDNA< 1 mile

Same-day Cervical Preparation Before Dilation and Evacuation

NCT03002441

The purpose of this randomized trial is to compare same-day cervical preparation using Dilapan-S™ plus buccal misoprostol to overnight cervical preparation using Dilapan-S™ before D\&E at 16.0 to 20.0 weeks. Primary objective: To compare D\&E operative time. We hypothesize that same-day Dilapan-S™ plus buccal misoprostol is non-inferior to overnight Dilapan-S™ with respect to operative time. Secondary objectives: To compare treatment groups for the following: Pre-operative cervical dilation; need for mechanical dilation and ease of dilation if required; ability to complete D\&E without further cervical preparation; ease of D\&E; complications; pain; side effects; patient and provider satisfaction.

Cervical Dilation Prior to Dilation and Evacuation

Planned Parenthood of Greater New York54 participantsStarted Dec 2016

New York, New York, United States

Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients

Same-day Cervical Preparation Before Dilation and Evacuation

Find Trials by Condition in New York

Efficacy and Safety Study of Polidocanol Injectable Foam for the Treatment of Saphenofemoral Junction (SFJ) Incompetence

Efficacy Evaluation of TheraSphere to Treat Inoperable Liver Cancer With Blockage of the Portal Vein

Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis

Multi-Beam Intensity-Modulated Radiation Therapy for Node-Positive Breast Cancer

Web-Based Decision Aid in Improving Informed Decisions in Patients With Stage 0-IIIA Breast Cancer Considering Contralateral Prophylactic Mastectomy

Anti-VEGF vs. Prompt Vitrectomy for VH From PDR

Treatment for Endogenous Cushing's Syndrome

Using Cinacalcet to Treat the Hypophosphatemia of Early Kidney Transplant

Anti-ageing Efficacy of a Cosmetic Formulation Containing NMN (2%) Versus Placebo

Heart Sounds Registry

A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis

The Functional and Emotional Benefits of Replenix Power of Three With Resveratrol

Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer

Fuzzy Logic Automated Insulin Regulation

Post Approval Study of the remedē System

Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain Cancer

Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients.

Hemoglobin Maintenance in Pediatric ESRD (End-stage Renal Disease) Patients by Ferric Pyrophosphate Citrate (FPC)